Literature DB >> 16720321

Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities.

Laurent O Mosnier1, John H Griffin.   

Abstract

The anticoagulant protein C system is a dual function cofactor-dependent system. On one hand, it is designed to regulate coagulation, maintain the fluidity of the vasculature and prevent thrombosis. On the other hand, the protein C pathway provides anti-inflammatory and cytoprotective activities. Protein C, a vitamin K-dependent serine protease zymogen that circulates in plasma, is converted by limited proteolysis to activated protein C (APC) by the thrombin-thrombomodulin-endothelial protein C receptor complex on endothelial surfaces. APC and the cofactors of the protein C pathway exert two major distinct types of activities, namely a well-studied anticoagulant activity and a more recently revealed cytoprotective activity due to direct effects on cells. Because of these pleiotropic properties, APC and the protein C pathway components have important roles in the body's host-defense system and provide opportunities for therapeutic treatment of complex and challenging medical disorders, including thrombosis, severe sepsis and stroke.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720321     DOI: 10.2741/1977

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  18 in total

1.  Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.

Authors:  Laurent O Mosnier
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

Review 2.  Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C.

Authors:  Arun Paul Amar; Abhay P Sagare; Zhen Zhao; Yaoming Wang; Amy R Nelson; John H Griffin; Berislav V Zlokovic
Journal:  Neuropharmacology       Date:  2017-09-18       Impact factor: 5.250

3.  Expression patterns and action analysis of genes associated with blood coagulation responses during rat liver regeneration.

Authors:  Li-Feng Zhao; Wei-Min Zhang; Cun-Shuan Xu
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

4.  Species-specific anticoagulant and mitogenic activities of murine protein S.

Authors:  José A Fernández; Mary J Heeb; Xiao Xu; Itender Singh; Berislav V Zlokovic; John H Griffin
Journal:  Haematologica       Date:  2009-10-08       Impact factor: 9.941

5.  Organ-specific protection against lipopolysaccharide-induced vascular leak is dependent on the endothelial protein C receptor.

Authors:  Annette von Drygalski; Christian Furlan-Freguia; Wolfram Ruf; John H Griffin; Laurent O Mosnier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-07       Impact factor: 8.311

Review 6.  Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis.

Authors:  Daniel De Backer
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 7.  Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy.

Authors:  Junru Wang; Marjan Boerma; Qiang Fu; Martin Hauer-Jensen
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

8.  Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant.

Authors:  Laurent O Mosnier; Antonella Zampolli; Edward J Kerschen; Reto A Schuepbach; Yajnavalka Banerjee; José A Fernández; Xia V Yang; Matthias Riewald; Hartmut Weiler; Zaverio M Ruggeri; John H Griffin
Journal:  Blood       Date:  2009-02-24       Impact factor: 22.113

9.  Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice.

Authors:  Hai Po H Liang; Edward J Kerschen; Sreemanti Basu; Irene Hernandez; Mark Zogg; Shuang Jia; Martin J Hessner; Raffaella Toso; Alireza R Rezaie; José A Fernández; Rodney M Camire; Wolfram Ruf; John H Griffin; Hartmut Weiler
Journal:  Blood       Date:  2015-09-04       Impact factor: 22.113

10.  Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies.

Authors:  Laith Altaweel; Daniel Sweeney; Xizhong Cui; Amisha Barochia; Charles Natanson; Peter Q Eichacker
Journal:  Biologics       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.